Read time: 1 minute

Mylan CEO Heather Bresch: 'No One's More Frustrated Than Me' About EpiPen Price Outrage

'Mylan CEO Heather Bresch struggled Thursday to justify the repeated big price hikes of the company's lifesaving EpiPen devices.'

I imagine Heather Bresch is frustrated right now. She's seen their stock price plunge 12% in the past few weeks since this controversy blew up in their faces. Bresch does a woeful job at damage control in this interview, the full length of which was nearly twenty minutes. Bresch could not adequately explain why her EpiPens which retail for $600 per set in the United States only cost about $100 in Canada and the UK, although she blamed the health-care system. That's about a 600% increase since Mylan took over the manufacture and distribution in 2009. And oddly enough, Bresch also stumbled when asked about her own 671% increase in salary over those years, from about $2.4m to $18.6m today.

Source: CNBC

Mylan CEO Heather Bresch struggled Thursday to justify the repeated big price hikes of the company's lifesaving EpiPen devices as criticism continued that Mylan is gouging consumers with a retail cost of more than $600.

"No one's more frustrated than me," Bresch told CNBC's "Squawk Box" on Thursday when she was pressed on the question of why Mylan needed to have such a high price for EpiPens, and why she just didn't cut their price.

"Everybody should be frustrated," said Bresch, who in recent days has come under fire from U.S. Senators, Democratic presidential nominee Hillary Clinton and patients who are outraged by EpiPen's 400-percent price increases in recent years.

Mylan, in response to that criticism, announced Thursday increased rebates to many consumers who rely on the devices, which are used to counteract potentially fatal allergic reactions known as anaphylaxis.

Bresch argued that the problem of drug prices isn't with Mylan or even the pharmaceutical industry, but instead with a health-care system that often requires consumers to pay not just insurance premiums also out-of-pocket for prescription medications, sometimes to the full retail price.

Can you help us out?

For 17 years we have been exposing Washington lies and untangling media deceit, but now Facebook is drowning us in an ocean of right wing lies. Please give a one-time or recurring donation, or buy a year's subscription for an ad-free experience. Thank you.

More C&L Coverage


New Commenting System

Our comments are now powered by Insticator. In order to comment you will need to create an Insticator account. The process is quick and simple. Please note that the ability to comment with a C&L site account is no longer available.

We welcome relevant, respectful comments. Any comments that are sexist or in any other way deemed hateful by our staff will be deleted and constitute grounds for a ban from posting on the site. Please refer to our Terms of Service (revised 3/17/2016) for information on our posting policy.

Please Do Not Use the Login Link at the Top of the Site.

In order to comment you must use an Insticator account. To register an account, enter your comment and click the post button. A dialog will then appear allowing you create your account.

We will be retiring our Crooks and Liars user account system in January, 2021.

Thank you.
C&L Team